FDA Inspection 1320030 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on Apr 30, 2026 in Jining. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2026
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Jining (China)